The Middle EAST Bioresorbable Coronary Stents Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by a combination of increasing cardiovascular diseases, advancements in medical technology, and a rising preference for minimally invasive procedures. The demand for bioresorbable stents...